Richard Whitley to Influenza, Human
This is a "connection" page, showing publications Richard Whitley has written about Influenza, Human.
Connection Strength
4.009
-
Oseltamivir for influenza - Authors' reply. Lancet. 2016 Jan 09; 387(10014):125.
Score: 0.440
-
Oseltamivir for influenza - Authors' reply. Lancet. 2015 Sep 19; 386(9999):1135-6.
Score: 0.431
-
Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials. Antivir Ther. 2015; 20(7):709-19.
Score: 0.404
-
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clin Infect Dis. 2013 May; 56(9):1197-205.
Score: 0.358
-
Of ferrets and humans: influenza pathogenesis. J Infect Dis. 2010 Apr 01; 201(7):976-7.
Score: 0.295
-
Seasonal and pandemic influenza: a 2007 update on challenges and solutions. Clin Infect Dis. 2008 Apr 01; 46(7):1024-31.
Score: 0.257
-
The role of oseltamivir in the treatment and prevention of influenza in children. Expert Opin Drug Metab Toxicol. 2007 Oct; 3(5):755-67.
Score: 0.248
-
Lessons learned from reconstructing the 1918 influenza pandemic. J Infect Dis. 2006 Nov 01; 194 Suppl 2:S127-32.
Score: 0.233
-
Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis. 2006 Nov 01; 194 Suppl 2:S133-8.
Score: 0.233
-
Seasonal and pandemic influenza: recommendations for preparedness in the United States. J Infect Dis. 2006 Nov 01; 194 Suppl 2:S155-61.
Score: 0.233
-
Seasonal and pandemic influenza preparedness: a global threat. J Infect Dis. 2006 Nov 01; 194 Suppl 2:S65-9.
Score: 0.233
-
Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001 Feb; 20(2):127-33.
Score: 0.156
-
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015 May 02; 385(9979):1729-1737.
Score: 0.103
-
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach. Clin Pharmacol Ther. 2014 Sep; 96(3):380-9.
Score: 0.098
-
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis. 2013 Mar 01; 207(5):709-20.
Score: 0.089
-
Oseltamivir dosing for influenza infection in premature neonates. J Infect Dis. 2010 Aug 15; 202(4):563-6.
Score: 0.076
-
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J. 2010 Mar; 29(3):195-8.
Score: 0.073
-
Antiviral therapy and pulmonary disease. Chest. 1987 Feb; 91(2):246-51.
Score: 0.015
-
Approaches to therapy of viral infections. Adv Pediatr. 1987; 34:89-110.
Score: 0.015
-
Current status of antiviral chemotherapy. South Med J. 1978 Sep; 71(9):1134-40.
Score: 0.008
-
Developmental aspects of selected antiviral chemotherapeutic agents. Annu Rev Microbiol. 1978; 32:285-300.
Score: 0.008